ArticleProceedings of the National Academy of Sciences of the United States of America2019

Prosurvival kinase PIM2 is a therapeutic target for eradication of chronic myeloid leukemia stem cells.

Leyuan Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.